| http://www.w3.org/ns/prov#value | - Compositions containing GLP-1(7-37) or its derivatives such as GLP-1(7-36) may be administered intravenously, intramuscularly, or sub-cutaneously at dosages in the range of from about 1 pg/kg to 1,000 ??g/kg body weight, or at concentrations sufficient to produce serum levels of 10???10 M to 10???11 M, although a lower or higher dosage may be administered.
|
